Gilead Sciences (GILD UW)

Analysis

Health Care • United States

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Refresh

Company Event • 15 Sep 2026 22:45 • Latest

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 10 Sep 2026 22:55

12th Annual Cantor Fitzgerald Global Healthcare Conference

Company Event • 09 Sep 2026 23:00

Wells Fargo 21st Annual Healthcare Conference

Company Event • 05 Aug 2026 04:30

Q2 2026

Company Event • 10 Jun 2026 01:20

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Morgan Stanley 24th Annual Global Healthcare Conference

12th Annual Cantor Fitzgerald Global Healthcare Conference

Wells Fargo 21st Annual Healthcare Conference

Q2 2026

Goldman Sachs 47th Annual Global Healthcare Conference 2026